References
- Fahy B, Bold R J. Epidemiology and molecular genetics of colorectal cancer. Surg Oncol 1998; 7: 115–123
- Rossouw J E, Anderson G L, Prentice R L, LaCroix A Z, Kooperberg C, Stefanick M L, Jackson R D, Beresford S A, Howard B V, Johnson K C, et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002; 288: 321–333
- Beral V, Bants E, Reeves G. Evidence from randomized trials on the long-term effects of hormone replacement therapy. Lancet 2002; 360: 942–944
- Marugo M, Molinari F, Fazzuoli L, Parodi M C, Bernasconi D, Menozzi F, Giordano G. Estradiol and progesterone receptors in normal and pathological colon mucosa in humans. J Endocrinol Invest 1985; 8: 117–119
- Singh S, Sheppard M C, Langman M J. Sex differences in the incidence of colorectal cancer: an exploration of estrogen and progesterone receptors. Gut 1993; 81: 611–615
- Campagnoli C, Abba C H, Ambroggio S, Peris C L. Pregnancy, progesterone and progestins in relation to breast cancer risk. J Steroid Biochem Molec Biol 2005; 97: 410–415
- Fernandez E, La Vecchia C, Balducci A, Chatenoud L, Franceschi S, Negri E. Oral contraceptives and colorectal cancer risk. Br J Cancer 2001; 84: 722–727
- Fernandez E, Franceschi S, La Vecchia C. Colorectal cancer and hormone replacement therapy: a review of epidemiological studies. Br J Menopause Soc 2004; 6: 8–14
- Franceschi S, La Vecchia C. Oral contraceptives and colorectal tumors: a review of epidemiological studies. Contraception 1998; 58: 335–343
- Mahavni V, Sood A K. Hormone replacement therapy and cancer risk. Curr Opin Oncol 2001; 13: 384–389
- La Vecchia C, Gallus S, Fernandez E. Hormone replacement therapy and colorectal cancer: an update. J Br Menopause Soc 2005; 11: 166–172
- Newcomb P A, Storer B E. Postmenopausal hormone use and risk of large bowel cancer. J Natl Cancer Inst 1995; 87: 1067–1071
- Prihartono N, Palmer J R, Louik C, Shapiro S, Rosenberg L. A case–control study of use of postmenopausal female hormone supplements in relation to the risk of large bowel cancer. Cancer Epidemiol Biomarkers Prev 2000; 9: 443–447
- Csizmadi I, Collett J P, Benedetti A, Boivin J F, Hanley J A. Defining hormone replacement therapy in longitudinal studies: impact on measures of effect. Pharmacoepidemiol Drug Safety 2004; 13: 205–225
- Slattery M L, Anderson K, Samowitz W, Edwards S L, Curtin K, Caan B, Potter J D. Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer. Cancer Causes Control 1999; 10: 467–473
- Mandelson M T, Miglioretti D, Newcomb P A, Harrison R, Potter J D. Hormone replacement therapy in relation to survival in women diagnosed with colon cancer. Cancer Causes Control 2003; 14: 979–984
- Olsson H, Bladström A, Inhvar C. Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy?. Obstet Gynecol 2003; 102: 565–570
- Purdue M P, Mink P J, Hartge P, Huang W Y, Buys S, Hayes R B. Hormone replacement therapy, reproductive history and colon adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial (United States). Cancer Causes Control 2005; 16: 965–973
- Woodson K, Lanza I, Tanges J A, Albert P S, Slattery M, Pinsky J, Caan B, Paskett E, Iber F, Kikendall J W, et al. Hormone therapy and colorectal adenoma recurrence among women in the Polyp Prevention trial. J Natl Cancer Inst 2001; 93: 1799–1805
- Risch H A, Howe G R. Menopausal hormone use and colorectal cancer in Saskatchewan: a record linkage cohort study. Cancer Epidemiol Biomarkers Prev 1995; 4: 21–28
- Anderson G L, Limacher M, Assaf A R, Bassford T, Beresford S A, Black H, Bonds D, Brunner R, Brzyski R, Caan B, et al. Women's Health Initiative Steering Committee. Effect of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2004; 291: 1701–1712
- Nazeri H, Khatibi A, Nyberg P, Agardh C D, Lidfeldt J, Samsioe G. Colorecteral cancer in middle-aged women in relation to hormonal status: a report from the Women's Health in the Lund Area (WHILA) study. Gynecol Endocrinol 2006; 22: 416–422